0001209191-22-017153.txt : 20220308 0001209191-22-017153.hdr.sgml : 20220308 20220308170015 ACCESSION NUMBER: 0001209191-22-017153 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220304 FILED AS OF DATE: 20220308 DATE AS OF CHANGE: 20220308 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Saad Mark E CENTRAL INDEX KEY: 0001295913 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37635 FILM NUMBER: 22722544 BUSINESS ADDRESS: BUSINESS PHONE: 858-458-0900 MAIL ADDRESS: STREET 1: C/O CYTORI THERAPEUTICS, INC. STREET 2: 3020 CALLAN ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axsome Therapeutics, Inc. CENTRAL INDEX KEY: 0001579428 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454241907 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 CORTLANDT STREET, 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 BUSINESS PHONE: (212) 332-3241 MAIL ADDRESS: STREET 1: 22 CORTLANDT STREET, 16TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10007 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-04 0 0001579428 Axsome Therapeutics, Inc. AXSM 0001295913 Saad Mark E C/O AXSOME THERAPEUTICS, INC. 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 1 0 0 0 Stock Option (Right to Buy) 29.91 2022-03-04 4 A 0 2337 0.00 A 2022-03-04 2032-03-03 Common Stock 2337 2337 D Represents 2,337 options elected to be received in lieu of cash compensation earned in 2021. All of such options are immediately exercisable. /s/ Herriot Tabuteau, M.D., Attorney in Fact 2022-03-08